Clinical trialPhase 3Terminated
Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer
Neoadjuvant Radiotherapy in Patients With Primary Resectable Adenocarcinoma of the Pancreatic Head Plus Adjuvant Chemotherapy: a Randomized Controlled Phase III Trial
- Outcome
- Stopped earlylack of recruitment (Enrollment)
- Phase
- Phase 3
- Status
- Terminated
- Study type
- Interventional
- Start
- October 2011
- Expected end
- October 2014
- Enrollment
- 5 participants
- Sites
- 1
- Primary outcomes
- Local recurrence free survival
- Sponsor
- Network
- Results posted
- No
- Last update
- 29 July 2015
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
Net-Pac investigates if radiation prior to surgical resection improves survival in patients with pancreatic head cancer without metastases.
Detailed description public domain (ClinicalTrials.gov)
The trial is designed to show that neoadjuvant radiotherapy followed by surgery improves local recurrence free survival compared to surgery alone in patients with resectable adenocarcinoma of the pancreatic head.